Table 2.
Peptide names | Physiochemical features | Tumor cell types | Description in applications | Refs. |
---|---|---|---|---|
PuraMatrix hydrogel (COCH3‐RADARADARADARADA‐CONH2) |
High‐water content; 3–6 kPa storage modulus; fibril entanglements |
A2780, A2780/DDP, SK‐OV‐3, OVCAR‐5 cells; MDA‐MB‐231 and MDA‐MB‐453 stem cells; hepG2 cells; PANC‐1 cells. |
Functionalized modification; Easy to isolate cells; Tumor heterogeneity; 3D culture; Drug sensitivity assay; Phenotype presentation |
[ 80 , 142 , 170 , 223 ] |
EAK16‐II Hydrogel (CONH3‐AEAEAKAKAEAEAKAK‐CONH2) |
The same as RADA16‐I hydrogel |
A549; MCF‐7 |
Easy to isolate cells; High cell viability Drug delivery nanocarrier; Low cytotoxicity; 3D cell culture. |
[ 229 ] |
H9e peptide hydrogel (FLIVIGSIIGPGGDGPGGD) |
Shear‐thinning and easy recovery Self‐assembling hydrogelation. |
MCF7 breast cancer cells |
Simple cell recovery Tumor‐like cell clusters Superior physiological properties Multiple cell assays; 3D cell cultures. |
[ 103 ] |
EFK8 hydrogel (EFK8‐I and EFK8‐II) (FEFEFKFK) (EFK8‐SWNT) |
Better mechanical strength Disperse carbon nanotubes |
NIH‐3T3 cells, A549 cancer cells, MCF7 cancer cells, pluripotent stem cells, MCF10A and MCF10DCIS. |
High cell anchorage for attachment, spreading, proliferation and movement The stretched morphology; 3D cell cultures Cell behavior assay Cell–peptide scaffold interactions. |
[ 64 , 207 ] |
MAX1 and MAX8 hydrogel [MAX1:VKVKVKVK‐VDPPT‐KVKVKVKV‐NH2; MAX8:VKVKVKVK‐VDPPT‐KVEVKVKV‐NH2] |
Shear‐thinning behavior Stiffness modulus G′ ≈600 Pa Solid hydrogels Rehealing or self‐healing hydrogel |
C3H10t1/2 stem cells Osteosarcoma MG63 cells ONS‐76 cells. |
Functionalized modification Low‐viscosity gel Unique gel‐cell constructs Homogeneous distribution Controllable hydrogelation Injectable solid hydrogels Drug delivery vehicle. |
[ 230 ] |
Q13 peptide hydrogel Q13(Ac‐QQKFQFQFEQEQQAm) Q11 (Ac‐QQKFQFQFEQQ‐Am) [P11‐I and P11‐II] |
Mildly basic pH Storage moduli 1–10 kPa stiff or rigid hydrogel |
C3H10T1/2 stem cells Prostate cancer cells (LNCaP). |
3D cell culture Tumor spheroid Chemosensitivity assay Scaffold modification 3D drug testing assay. |
[ 114b ] |
Multidomain peptide hydrogel [K2(SL)6K2 and K(SL)3RG(SL)3KGRGDS] |
Ionic or covalent hydrogelation Compatible with ECM Injectable hydrogel. |
MOC2‐E6E7, the murine oral cancer cell line; SHED cells |
Eightfold slower release rate in collagen hydrogel Easily delivered by syringe Mimic microenvironments in vivo for more complex tissues. |
[ 123 , 231 ] |
Fmoc dipeptides [Fmoc‐LL, YL, LY, YY] |
MMP‐9 triggered gelation Micelle‐to‐fiber transition. |
MDA‐MB‐231‐luc‐D3H2LN cells HEK‐293T cells Osteosarcoma SaOs2 cells; ATDC5 cells. |
Enzyme‐responsive properties Tunable properties Site‐specific drug release The fibrillar depots Biocatalytic self‐assembly Variable rigidity and stiffness. |
[ 125 , 232 ] |